| Literature DB >> 28084526 |
C Röcken1.
Abstract
Gastric cancer is the fifth (men) and sixth (women) most common cause of cancer-related death in Germany. Despite a declining incidence of distal gastric cancer, the prognosis remains dismal: the 5‑year survival rate ranges between 35% for women and 31% for men. The majority are adenocarcinomas, which occur sporadically, familial or hereditary. Adenomas and intraepithelial neoplasms are considered as precursor lesions. Recently, whole genome sequencing and comprehensive molecular profiling described four molecular subtypes of gastric cancer: Epstein-Barr virus (EBV) positive, microsatellite unstable, chromosomal unstable and genomically stable gastric cancer. Currently, only the TNM classification has stood the test of time for the assessment of patient prognosis. Neuroendocrine tumor types 1-3 and soft tissue tumors occur significantly less often in the stomach. Gastrointestinal stromal tumors and inflammatory fibroid polyps are among the more common soft tissue tumors of the stomach and show distinct phenotypes. This review gives an overview of the current World Health Organization (WHO) classification of gastric tumors.Entities:
Keywords: Gastric cancer; Gastrointestinal tract; Inflammatory fibroid polyp; Intraepithelial neoplasia; Neuroendocrine neoplasia; WHO classification
Mesh:
Year: 2017 PMID: 28084526 DOI: 10.1007/s00292-016-0259-4
Source DB: PubMed Journal: Pathologe ISSN: 0172-8113 Impact factor: 1.011